Arch Therapeutics Stock Price Prediction

Intrinsic Valuation Low Real High 0.01 0.19 18.92 Details

Arch Therapeutics After-Hype Price Prediction Density Analysis

Arch Therapeutics Estimiated After-Hype Price Volatility

Arch Therapeutics OTC Stock Price Prediction Analysis

Expected Return	Period Volatility	Hype Elasticity	Related Elasticity	News Density	Related Density	Expected Hype
0.28	18.73	0.00	0.10	0 Events / Month	5 Events / Month	In 5 to 10 days

Latest traded price	Expected after-news price	Potential return on next major news	Average after-hype volatility
0.20	0.20	0.00	0.00   Notes

Arch Therapeutics Hype Timeline

Arch Therapeutics is presently traded for 0.20. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.1. Arch is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is presently at 0.28%. %. The volatility of related hype on Arch Therapeutics is about 5131.51%, with the expected price after the next announcement by competition of 0.30. About 15.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.02. Arch Therapeutics had not issued any dividends in recent years. The entity had 1:200 split on the 18th of January 2023. Given the investment horizon of 90 days the next anticipated press release will be in 5 to 10 days. Check out Arch Therapeutics Basic Forecasting Models to cross-verify your projections.

Arch Therapeutics Related Hype Analysis

Arch Therapeutics Additional Predictive Modules

Most predictive techniques to examine Arch price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Arch using various technical indicators. When you analyze Arch charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

The successful prediction of Arch Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Arch Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Arch Therapeutics based on analysis of Arch Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.

The number of cover stories for Arch Therapeutics depends on current market conditions and Arch Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Arch Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Arch Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Arch Therapeutics' future price predictability will typically decrease when Arch Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Arch Therapeutics often depends not only on the future outlook of the potential Arch Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Arch Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.

When running Arch Therapeutics' price analysis, check to measure Arch Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arch Therapeutics is operating at the current time. Most of Arch Therapeutics' value examination focuses on studying past and present price action to predict the probability of Arch Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arch Therapeutics' price. Additionally, you may evaluate how the addition of Arch Therapeutics to your portfolios can decrease your overall portfolio volatility.